Anti-insulin antibodies and metabolic deterioration after interruption of continuous subcutaneous insulin infusion.
D020155:3-Hydroxybutyric Acid; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D006885:Hydroxybutyrates / Q000097:blood; D007330:Insulin Antibodies / Q000096:biosynthesis*; D007332:Insulin Infusion Systems / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
D001786:Blood Glucose; D006885:Hydroxybutyrates; D007330:Insulin Antibodies; D020155:3-Hydroxybutyric Acid